The ASTCT Pharmacy New Investigator Award is designed to encourage clinical, laboratory/translational medicine, pharmacoeconomic, or health services research by young investigators in the field of blood and marrow transplantation.
The award, $25,000 per year for two years, may be used for direct support of research costs and/or to support the investigator’s salary for his or her research effort.
To be eligible for the New Investigator Award, the applicant must be a licensed pharmacist (PharmD) who has completed ≥2 years of postdoctoral training and is not beyond 7 years from finishing training at the time of grant submission. Applicants in midst of their PGY1 or PGY2 residency at time of grant submission are not eligible for the grant award.
Grant applications from candidates with existing career development awards (such as K23, K08, or any other type of career development award) will not be considered, nor will applications from candidates with independent, non-mentored peer-reviewed funding (such as R01, P01 or comparable).
Applicants may submit only one application per cycle. Applicants with other funding that overlaps an approved application’s scope of work must choose one or the other but may not keep both. This applies up to and through the duration of the funded project.
Applicants are required to be an ASTCT and ASTCT Pharmacy Special Interest Group member. An applicant must have a sponsor who is an ASTCT member. The sponsor serves as a mentor for the applicant’s research and career development. The sponsor does not have to be a PharmD.
Judging and Evaluation Criteria
New Investigator Award applications will be evaluated for (a) scientific merit within the field of blood and marrow transplantation, (b) significance and anticipated overall impact of the potential findings, (c) institutional environment, (d) the training record of the sponsor/mentor, and (e) the potential contribution of the proposed research to the field of blood and marrow transplantation. Inclusion of preliminary data in the proposal is highly encouraged.
Currently, the ASTCT Pharmacy SIG Research Committee would like to extend to you an opportunity to join the pool of potential reviewers for the 2017 ASTCT Pharmacy New Investigator Award review panel. Please indicate your top two areas of expertise and send you CV to Katie Culos (email@example.com) by March 13th, 2017.
An initial Letter of Intent will be due no later than Friday, June 2, 2017 (5:00 pm CST). Click here for full instructions. The Letters of Intent will be evaluated by the ASTCT SIG New Investigator Research Award Review Panel, and submission of full applications will be invited for eligible projects, due date TBD.
Eligible applicants are required to submit the full application materials (below) no later than September 15th, 2017:
- New Investigator Award application
- Curriculum Vitae (that adheres to the NIH biographical sketch format)
- List of Other Support (that adheres to the NIH format)
- Letter of recommendation from the sponsor/mentor (maximum two pages)
- Description of the proposed research (maximum four pages)
The award winner(s) will be notified November 17th 2017, in time to make arrangements to attend the 2018 BMT Tandem Meetings, in Salt Lake City, Utah. The award(s) will be publicly announced at this meeting. The award will be activated July 1, 2018.
The award will be $25,000 for the first year, renewable for an additional $25,000 for a second year, contingent upon a report of satisfactory progress, which must be submitted to the ASTCT executive office no later than June 1, 2019.